You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
20 November 2019 - Eli Lilly and Company (NYSE: LLY) announced on Wednesday the investment of USD400m in its manufacturing facilities at its Lilly Technology Centre campus in Indianapolis.The details of the investments, were unveiled by company leade...
20 November 2019 - Biotechnology company Kymera Therapeutics Inc announced on Wednesday that Nello Mainolfi, PhD, Kymera co-founder, president and chief scientific officer has been promoted to president and chief executive officer with immediate effe...
20 November 2019 - The United States Food and Drug Administration (FDA) has approved United States-based Pfizer Incorporated's (NYSE: PFE) ABRILADA (adalimumab-afzb), as a biosimilar to Humira (adalimumab), intended for the treatment of certain ...
20 November 2019 - United States-based Dicerna Pharmaceuticals has signed a contract with Denmark-based Novo Nordisk for discovering and developing drugs for liver-related cardio-metabolic diseases, it was reported yesterday.Both firms will make use ...
20 November 2019 - Genmab A/S (CPH:GMAB), a biotechnology company specialising in the creation and development of differentiated antibody therapeutics for the treatment of cancer, announced on Tuesday the grant by the European Commission (EC) of mark...
19 November 2019 - - US-based pharmaceutical company Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) and Denmark-based Novo Nordisk A/S have inked an agreement to discover and develop novel therapies for the treatment of liver-related car...
19 November 2019 - - British-Swedish pharmaceutical company AstraZeneca (OTC: AZNCF) released new data from five additional analyses of the landmark Phase III DAPA-HF trial, which showed that Farxiga (dapagliflozin) reduced the risk of the primary co...